According to the Summary of Product Characteristics (SmPC), nausea occurs in approximately 20% of patients taking semaglutide (Ozempic), up to 21% with dulaglutide (Trulicity), and 20-40% with liraglutide (Saxenda), depending on dose
Engineered for healthy-looking skin Like an engine, skin requires maintenance
Consumption by humans or animals is strictly forbidden
While medications such as Mounjaro may have specific timing requirements, Wegovy's timing flexibility makes it easier for patients to integrate the treatment into their weekly schedule, promoting better adherence and potentially improving treatment outcomes
Gut-kidney crosstalk in septic acute kidney injury
Clinical studies have shown that semaglutide can help patients lose up to 15% of their body weight over time when combined with a healthy diet and exercise